Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Custom Antibody Market size worth $ 716.51 Million, Globally, by 2028 at 9.76% CAGR: Verified Market Research®

This image opens in the lightbox

News provided by

Verified Market Research

02 Feb, 2022, 15:15 GMT

Share this article

Share toX

Share this article

Share toX

- Elements such as expanding research activity in biotechnology and pharma industries along with rising alliance between industry and academic centers are the major growth driver of the Custom Antibody Market.

JERSEY CITY, N.J., Feb. 2, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Custom Antibody Market" By Type (Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies), By Source (Rabbits, Mice), By Application (Pharmaceuticals, Academic and Research Organizations). According to Verified Market Research, the Global Custom Antibody Market size was valued at USD 337.65 Million in 2020 and is projected to reach USD 716.51 Million by 2028, growing at a CAGR of 9.76% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=157049

Browse in-depth TOC on "Custom Antibody Market"

202 - Pages
126 – Tables
37 – Figures

Global Custom Antibody Market Overview

Custom antibody services are the procedure of customizing antibodies for applications in research and development. The rising demand for the latest medical diagnostic techniques has increased to an appreciable extent in recent years. This growth can be allocated to increasing prevalence rates, increasingly concerned about public health issues among the technological advancements, common population, that have authorized customized products with high-quality standards, rise in spending on the healthcare sector.

Custom antibody services are used by hospitals to treat immune system diseases such as cancer and other ailments. The operation of custom antibody services in health care centers is expanding because of the speedy diagnosis procedure with less turnaround time. Moreover, the exactness level is big which means that patients have very few chances of misdiagnosis. In addition, it is a very cost-effective method for hospitals as compared to other diagnostic methods. Custom Antibody Services are used in Bioscience Research Institutes to discover new biomarkers. This helps researchers upgrade the standard of research by exposing diseases at their starting stage and also diminishes their expenditure on commercial antibody services. This is because custom antibodies can be spread for specific targets, which cannot be done with available commercial antibodies or kits.

Custom antibody mainly used by hospitals to diagnose immune system disease, cancer, and other ailments. The factors that drive the market are a rise in the number of hospitals, an increase in spending on healthcare by governments, and raising awareness about the disease. Also, the growth of personalized medicine for cancer will further fuel the demand for custom antibody services over the forecast period

Key Developments

  • In 2021, Abcam plc and Abingdon Health (UK) entered into a collaboration and co-marketing agreement to increase Abcam's customer base.
  • In 2021, GenScript and SunRock Biopharma entered into a collaboration to develop therapeutic antibody candidates. GenScript will provide solutions to SunRock Biopharma for antibody discovery, cell line development, process development for GMP drug substances, and drug product manufacturing services.
  • In 2020, Thermo Fisher Scientific and BATL at Northeastern University entered into a collaborative agreement to advance analytical capabilities and drive innovation across the biopharmaceutical industry in various areas, including personalized medicine, monoclonal antibodies, and gene and cell therapies.

Key Players

The major players in the market are Merck Group, Abcam plc, BioLegend Inc., Agilent Technologies Inc., ProMab Biotechnologies, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., GenScript, Cell Signaling Technology, Inc., Rockland Immunochemicals and among others.

Verified Market Research has segmented the Global Custom Antibody Market On the basis of Type, Source, Application, and Geography.

  • Custom Antibody Market, By Type
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies
    • Other Custom Antibodies
  • Custom Antibody Market, By Source
    • Rabbits
    • Mice
    • Others
  • Custom Antibody Market, By Application
    • Pharmaceutical
    • Academic and Research Organization
    • Others
  • Custom Antibody Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Antinuclear Antibody Test Market By Product (Reagents And Assay Kits, Systems, Software And Services), By Technique (Elisa, Immunofluorescence Assay, Multiplex Assay), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Scleroderma), By Geography, Forecast, 2021-2028

High Throughput Screening Market By Product And Service (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software), By Technology (Cell-Based Assays, Lab-On-A-Chip, Ultra-High-Throughput Screening), By Application (Target Identification and Validation, Primary and Secondary Screening), By End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes), By Geography, Forecast, 2021-2028

Research Antibodies Market By Technology (Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes), By Product (Reagents and Antibodies), By Application (Proteomics, Drug Development, and Genomics), By Geography, Forecast, 2021-2028

Immunoassay Market By Product (Reagents and Kits and Analyzers), By Specimen (Urine, Blood, Saliva, & others), By Application (Cardiology, Blood Screening, Autoimmune Disorders & Others), By Technology (ELISA, Rapid Tests, Radio-Immuno Assay, Western Blotting), By End User (Research & Academic Laboratories, Home Care Settings, Pharmaceutical and Biotechnology Companies & CROs), By Geography, Forecast, 2021-2028

Top 10 Antibody Reagent Companies detecting reagents for protecting patients

Visualize Custom Antibody Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo:  https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

Modal title

Also from this source

Hospital Asset Management Market is expected to generate a revenue of USD 414.18 Billion by 2032, Globally, at 30.60% CAGR: Verified Market Research®

Hospital Asset Management Market is expected to generate a revenue of USD 414.18 Billion by 2032, Globally, at 30.60% CAGR: Verified Market Research®

The Global Hospital Asset Management Market Size is projected to grow at a CAGR of 30.60% from 2026 to 2032, according to a new report published by...

Dynamic Positioning System Market is expected to generate a revenue of USD 2.84 Billion by 2031, Globally, at 5.5% CAGR: Verified Market Research®

Dynamic Positioning System Market is expected to generate a revenue of USD 2.84 Billion by 2031, Globally, at 5.5% CAGR: Verified Market Research®

The Global Dynamic Positioning System Market Size is projected to grow at a CAGR of 5.5% from 2024 to 2031, according to a new report published by...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.